newsfilter
← Latest News
Business Wire·

PhaseBio Pharmaceuticals to Present at 23rd Annual H.C. Wainwright Global Investment Conference

PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced that Chief Financial Officer John Sharp will provi